Dipna Pharmachem Complete Financial Statements

DPL • Review detailed financials to uncover trends, confirm thesis & journal trades
8 Years of Data
2025 - 2018

Complete Financial Data Export

Export complete financial statements for Dipna Pharmachem (DPL). Downloads include all available records across all periods. For market performance, see the DPL stock price today .

Profitability Ratios

Net Profit Margin 0.80% 2025 data
EBITDA Margin 2.40% 2025 data
Operating Margin 3.00% 2025 data
Return on Assets 0.76% 2025 data
Return on Equity 2.56% 2025 data

Balance Sheet Ratios

Current Ratio 14.67 2025 data
Debt to Equity 3.38 2025 data
Equity Ratio 29.55% 2025 data
Asset Turnover 0.95 2025 data

Year-over-Year Growth Analysis

Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
-0.8%
Year-over-Year
Equity Growth
+2.6%
Year-over-Year
Liabilities Growth
-0.8%
Year-over-Year
Operating Cash Flow Growth
-80.0%
Year-over-Year
Financing Cash Flow Growth
-128.6%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018
Revenue 0 125 164 100 73 31 31 20 17
Expenses 0 122 161 98 71 31 31 20 17
EBITDA 0 3 3 2 2 0 0 0 0
Operating Profit Margin % 0.00% 3.00% 2.00% 2.00% 3.00% 1.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0
Interest 0 2 2 1 1 0 0 0 0
Profit Before Tax 0 1 1 1 2 0 0 0 0
Tax 0 0 0 1 0 0 0 0 0
Net Profit 0 1 1 1 1 0 0 0 0
Earnings Per Share (₹) 0.00 0.41 0.45 0.76 333.39 6.91 16.86 9.15 17.27

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018
ASSETS
Total Assets 132 133 78 36 25 18 14 11
Current Assets 132 133 78 36 25 18 14 11
Fixed Assets 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0
Other Assets 132 133 78 36 25 18 14 11
LIABILITIES
Total Liabilities 132 133 78 36 25 18 14 11
Current Liabilities 9 13 11 6 4 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 39 38 24 2 1 1 1 1
Share Capital 24 24 12 0 0 0 0 0
Reserves & Surplus 14 14 12 2 1 1 1 0

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -9 -5 -21 3 -2 -3
Investing Activities 0 0 0 0 0 0
Financing Activities -4 14 27 -3 3 3
Net Cash Flow -13 8 6 0 0 0